MEK1/2 inhibitor ATR-002 reshapes host transcriptome and modulates immune regulatory genes in SARS-CoV-2 infection - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

ATR-002, a MEK1/2 Inhibitor, Alters Host Transcriptomic Landscape and Influences Immune Regulatory Gene Expression During SARS-CoV-2 Infection

  • By

  • Franziska Rodner

  • Klaus Schughart

  • Stephan Ludwig

  • André Schreiber

  • May 29, 2026

Share

Original Source(s)

MEK1/2 inhibitor ATR-002 reshapes host transcriptome and modulates immune regulatory genes in SARS-CoV-2 infection

  • by Franziska Rodner, Klaus Schughart, Stephan Ludwig, André Schreiber

  • May 29, 2026

Related Content

Integrated transcriptomic and immune analysis reveals distinct mitochondrial and immune signature in COVID-19 ARDS requiring invasive mechanical ventilation

Same-Day COVID, Flu Vaccination Appears Safe

Study found no increased 90-day risk of serious adverse events with coadministration compared with vaccination alone.

Top 10 evidence-based essentials in infectious disease

A structured framework of guidelines, trials, therapies, and tools used in clinical practice